Method, device and storage medium for determining the state of tumor mutation load

By obtaining gene combination and whole exon sequencing data, combining tumor type, and calculating tumor mutation load status, the problem of differences in evaluation between gene combination products and cancer types in the existing technology is solved, and the accurate evaluation of tumor mutation load is achieved and Unified standards.

CN114267410BActive Publication Date: 2024-12-06CARRIER GENE TECH SUZHOU CO LTD +1
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202210125429.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-02-10
Publication Date
2024-12-06
Estimated Expiration
2042-02-10

AI Technical Summary

Technical Problem

The prior art is difficult to uniformly standardize the evaluation of tumor mutation burden status of gene combination products of different companies and the distribution of tumor mutation burden among different cancer types, and ignore the impact of population differences on thresholds.

Method used

By obtaining gene combination sequencing data and whole exon sequencing results, combining the data associated with tumor types, calculate and determine the tumor mutation load status, and using a summary method of multiple whole exon sequencing results to determine tumor mutations based on different tumor types. The load level.

Benefits of technology

Accurate tumor mutation burden status assessment for different gene combinations and tumor types is achieved, and the distribution differences and population differences between different cancer species are taken into account, providing unified evaluation criteria.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114267410B_ABST
    Figure CN114267410B_ABST
Patent Text Reader

Abstract

Embodiments of the present disclosure relate to methods, electronic devices, and storage media for determining the state of tumor mutation load, and relate to the field of bioinformatics. According to the method, sequencing data for a gene combination and the length of the capture region of the gene combination are obtained, the sequencing data is associated with a tumor sample of a target object, and the tumor sample is associated with a target tumor type; based on the sequencing data and the length, a first tumor mutation load is determined; multiple whole exon sequencing results of multiple objects associated with the target tumor type are obtained; for each whole exon sequencing result, based on the whole exon sequencing result and the length, a second tumor mutation load in the capture region of the gene combination is determined; and based on the first tumor mutation load and multiple second tumor mutation loads associated with multiple whole exon sequencing results, the state of the tumor mutation load of the target object is determined. Thus, it is possible to determine the state of the tumor mutation load for a gene combination and a tumor type.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] Embodiments of the present disclosure generally relate to the field of bioinformatics, and more particularly to methods, electronic devices, and computer storage media for determining the state of tumor mutation load. Background Art

[0002] Tumor mutation burden (TMB) refers to the total number of point mutations and insertion / deletion mutations per megabase in the exon coding region of the tumor cell genome. Tumor mutation burden was initially used as a biomarker to predict the efficacy of ipilimumab or tremelimumab in the treatment of patients with advanced melanoma. However, with the increase in research, tumor mutation burden has been found to have corresponding efficacy prediction effects in other cancers (such as non-small cell lung cancer, head and neck squamous cell carcinoma, small cell lung cancer and urothelial carcinoma). Therefore, tumor mutation burden is becoming an independent biomarker for the efficacy of PD-1 / PD-L1 and CTLA-4 inhibitors. On June 16, 2020, the U.S. Food and Drug Administration (FDA) approved pembrolizumab monotherapy for the treatment of adult and pediatric solid tumors with unresectable or metastatic tumor tissue samples with a high mutation burden (TMB-H) of ≥10 mutations / Mb (megabase). Next-Generation Sequencing (NGS) has been widely used in cancer diagnosis and medication guidance. F1CDx estimates the tumor mutation burden by detecting mutations in a 324-gene panel. Summary of the invention

[0003] Provided are a method, an electronic device, and a computer storage medium for determining the state of a tumor mutation load, which can determine the state of a tumor mutation load for a gene combination and a tumor type.

[0004] According to the first aspect of the present disclosure, a method for determining the state of a tumor mutation load is provided. The method includes: obtaining sequencing data for a gene combination and the length of a capture region of the gene combination, the sequencing data being associated with a tumor sample of a target object, and the tumor sample being associated with a target tumor type; determining a first tumor mutation load based on the sequencing data and the length of the capture region of the gene combination; obtaining multiple whole exome sequencing results of multiple objects associated with the target tumor type; for each whole exome sequencing result in the multiple whole exome sequencing results, determining a second tumor mutation load in the capture region of the gene combination based on the whole exome sequencing result and the length of the capture region of the gene combination; and determining the state of the tumor mutation load of the target object based on the first tumor mutation load and multiple second tumor mutation loads associated with the multiple whole exome sequencing results.

[0005] According to a second aspect of the present disclosure, an electronic device is provided. The electronic device includes: at least one processor; and a memory connected to the at least one processor in communication; wherein the memory stores instructions executable by the at least one processor, and the instructions are executed by the at least one processor so that the at least one processor can execute the method according to the first aspect of the present disclosure.

[0006] In a third aspect of the present disclosure, a computer-readable storage medium is provided, on which a computer program is stored, and when the program is executed by a processor, the method according to the first aspect of the present disclosure is implemented.

[0007] It should be understood that the content described in this section is not intended to identify the key or important features of the embodiments of the present disclosure, nor is it intended to limit the scope of the present disclosure. Other features of the present disclosure will become easily understood through the following description. BRIEF DESCRIPTION OF THE DRAWINGS

[0008] The above and other features, advantages and aspects of the embodiments of the present disclosure will become more apparent with reference to the following detailed description in conjunction with the accompanying drawings. In the accompanying drawings, the same or similar reference numerals represent the same or similar elements.

[0009] Figure 1 is a schematic block diagram of an information processing environment 100 according to an embodiment of the present disclosure.

[0010] Figure 2 is a schematic diagram of a method 200 for determining the status of a tumor mutation load according to an embodiment of the present disclosure.

[0011] Figure 3 is a schematic diagram of a method 300 for determining a state of a tumor mutation load of a target subject according to an embodiment of the present disclosure.

[0012] Figure 4 400 is a comparison chart of tumor mutation burden distribution of gene combination sequencing and whole exome sequencing according to an embodiment of the present disclosure.

[0013] Figure 5 is a schematic block diagram of an electronic device for implementing a method for determining a state of a tumor mutation load according to an embodiment of the present disclosure. DETAILED DESCRIPTION

[0014] The following is a description of exemplary embodiments of the present disclosure in conjunction with the accompanying drawings, including various details of the embodiments of the present disclosure to facilitate understanding, which should be considered as merely exemplary. Therefore, it should be recognized by those of ordinary skill in the art that various changes and modifications may be made to the embodiments described herein without departing from the scope and spirit of the present disclosure. Similarly, for the sake of clarity and conciseness, descriptions of well-known functions and structures are omitted in the following description.

[0015] As used herein, the term "including" and its variations mean open inclusion, i.e., "including but not limited to". Unless otherwise stated, the term "or" means "and / or". The term "based on" means "based at least in part on". The terms "an example embodiment" and "an embodiment" mean "at least one example embodiment". The term "another embodiment" means "at least one additional embodiment". The terms "first", "second", etc. may refer to different or the same objects. Other explicit and implicit definitions may also be included below.

[0016] As mentioned above, F1CDx estimates the level of tumor mutation load by detecting mutations in a 324-gene panel. However, many tumor sequencing companies have launched their own gene panel sequencing products, and most cancer patients use non-F1CDx combination products for genetic testing. Since there is no unified standard for the threshold of tumor mutation load, many clinical trials use different thresholds, such as F1CDx's 10 / Mb, and the clinical trial KEYNOTE-012 uses 102 mutations. In addition, the different number of genes contained in each gene panel will also cause changes in the threshold. Therefore, a solution is needed to judge the status of the tumor mutation load of gene combination products from different companies.

[0017] In addition, the thresholds of most detection products do not distinguish between cancer types, and the distribution of tumor mutation loads is inconsistent among different cancer types, making it difficult to use a unified standard to evaluate the tumor mutation load of different cancer types. In addition, traditional solutions ignore the impact of population issues on the threshold of tumor mutation load.

[0018] In order to at least partially solve one or more of the above problems and other potential problems, the exemplary embodiments of the present disclosure propose a scheme for determining the state of tumor mutation load. In this scheme, sequencing data for a gene combination and the length of the capture region of the gene combination are obtained, the sequencing data is associated with a tumor sample of a target object, and the tumor sample is associated with a target tumor type; based on the sequencing data and the length of the capture region of the gene combination, a first tumor mutation load is determined; multiple whole exome sequencing results of multiple objects associated with the target tumor type are obtained; for each whole exome sequencing result in the multiple whole exome sequencing results, based on the whole exome sequencing result and the length of the capture region of the gene combination, a second tumor mutation load in the capture region of the gene combination is determined; and based on the first tumor mutation load and multiple second tumor mutation loads associated with the multiple whole exome sequencing results, the state of the tumor mutation load of the target object is determined.

[0019] According to the scheme of the present disclosure, by obtaining multiple whole exome sequencing results of multiple objects associated with the target tumor type, and determining the second tumor mutation load summarized in the capture region of the gene combination for each whole exome sequencing result, the state of the tumor mutation load of the target object can be determined based on the multiple second tumor mutation loads associated with the multiple whole exome sequencing results, thereby achieving the determination of the state of the tumor mutation load for the gene combination and tumor type.

[0020] Hereinafter, specific examples of the present solution will be described in more detail with reference to the accompanying drawings.

[0021] Figure 1 FIG. 1 is a schematic block diagram of an information processing environment 100 according to an embodiment of the present disclosure. The information processing environment 100 may include an electronic device 110 .

[0022] The electronic device 110 includes, for example, but is not limited to, a personal computer, a desktop computer, a laptop computer, a smart phone, a personal digital assistant, a server, etc.

[0023] The information processing environment 100 may also include sequencing data 120 for a gene combination. The sequencing data 120 is associated with a tumor sample of a target subject. The tumor sample is associated with a target tumor type. The subject may include, for example, an individual. The target tumor type may include various suitable tumor types.

[0024] The information processing environment 100 may also include the length 130 of the captured region of the gene combination, multiple whole exome sequencing results 140 of multiple subjects (1-n subjects, n greater than or equal to 0) associated with the target tumor type, and the status 150 of the tumor mutation load of the target subject.

[0025] The electronic device 110 is used to obtain sequencing data 120 for a gene combination and a length 130 of a capture region of the gene combination, wherein the sequencing data 120 is associated with a tumor sample of a target object, and the tumor sample is associated with a target tumor type; based on the sequencing data 120 and the length 130 of the capture region of the gene combination, a first tumor mutation load is determined; multiple whole exome sequencing results 140 of multiple objects associated with the target tumor type are obtained; for each whole exome sequencing result in the multiple whole exome sequencing results 140, a second tumor mutation load in the capture region of the gene combination is determined based on the whole exome sequencing result and the length 130 of the capture region of the gene combination; and based on the first tumor mutation load and multiple second tumor mutation loads associated with the multiple whole exome sequencing results, a state 150 of the tumor mutation load of the target object is determined.

[0026] Therefore, by obtaining multiple whole exome sequencing results of multiple objects associated with the target tumor type, and determining the second tumor mutation load summarized in the capture region of the gene combination for each whole exome sequencing result, the state of the tumor mutation load of the target object can be determined based on the multiple second tumor mutation loads associated with the multiple whole exome sequencing results, thereby achieving the determination of the state of the tumor mutation load for the gene combination and tumor type.

[0027] Figure 2 FIG. 2 is a flowchart of a method 200 for determining a state of a tumor mutation load according to an embodiment of the present disclosure. For example, the method 200 may be performed as follows: Figure 1 The method 200 is performed by the electronic device 110 shown. It should be understood that the method 200 may further include additional blocks not shown and / or may omit the blocks shown, and the scope of the present disclosure is not limited in this respect.

[0028] At block 202 , the electronic device 110 acquires sequencing data 120 for a gene combination and a length 130 of a capture region of the gene combination, the sequencing data 120 being associated with a tumor sample of a target subject, the tumor sample being associated with a target tumor type.

[0029] It should be understood that the length of the capture region of the gene combination refers to the number of bases included in the gene combination, for example, in megabases Mb.

[0030] At block 204 , the electronic device 110 determines a first tumor mutation load based on the sequencing data 120 and the length 130 of the capture region of the gene combination.

[0031] Specifically, the electronic device 110 may determine a first number of mutations whose variant allele frequency is greater than a predetermined value based on the sequencing data 120. The predetermined value includes, but is not limited to, 5%.

[0032] Subsequently, the electronic device 110 may determine a first tumor mutation load based on the first number of mutations having a variant allele frequency greater than a predetermined value and the length 130 of the capture region of the gene combination. For example, the first tumor mutation load is determined by dividing the first number of mutations having a variant allele frequency greater than a predetermined value by the length of the capture region of the gene combination.

[0033] It should be understood that mutations in sequencing data include synonymous mutations and non-synonymous mutations. Non-synonymous mutations may include point mutations and insertion / deletion mutations.

[0034] At block 206 , the electronic device 110 obtains a plurality of whole exome sequencing results 140 for a plurality of subjects associated with a target tumor type.

[0035] In some embodiments, the electronic device 110 may obtain multiple whole exome sequencing result sets for multiple object sets associated with multiple tumor types, and the multiple tumor types include a target tumor type. For example, the electronic device 110 may obtain multiple whole exome sequencing result sets for multiple object sets associated with multiple tumor types from a database. The database may be stored in the electronic device 110 or may be connected to the electronic device 110 in communication. Multiple tumor types include, for example, but are not limited to, glioma, colorectal cancer, hepatocellular carcinoma, glioblastoma, lung adenocarcinoma, soft tissue sarcoma, gastric cancer, bile duct cancer, breast cancer, medulloblastoma, pancreatic cancer, non-small cell lung cancer, renal cancer, esophageal cancer, head and neck tumors, non-Hodgkin's lymphoma, etc.

[0036] Subsequently, the electronic device 110 may obtain a plurality of whole exome sequencing results 140 of a plurality of subjects associated with the target tumor type from a plurality of whole exome sequencing result sets.

[0037] It should be understood that the mutations in the whole exome sequencing results only include non-synonymous mutations. Non-synonymous mutations may include point mutations and insertion / deletion mutations.

[0038] In some embodiments, the plurality of object sets and the target object belong to the same ethnic group, which includes, but is not limited to, Chinese.

[0039] In other embodiments, the plurality of object sets are associated with a plurality of populations, and the plurality of objects and the target object belong to the same population.

[0040] Thus, the state of the tumor mutation burden of the target subject can be determined by considering multiple whole exome sequencing results of multiple subjects belonging to the same population as the target subject.

[0041] At block 208 , the electronic device 110 determines, for each whole exome sequencing result in the plurality of whole exome sequencing results, a second tumor mutation burden in the capture region of the gene combination based on the whole exome sequencing result and the length 130 of the capture region of the gene combination.

[0042] Specifically, the electronic device 110 may determine, based on the whole exome sequencing result, a second number of mutations in the captured region of the gene combination whose variant allele frequency is greater than a predetermined value.

[0043] Subsequently, the electronic device 110 may determine the second tumor mutation load in the captured region of the gene combination based on the second number of mutations in the captured region of the gene combination whose variant allele frequency is greater than a predetermined value and the length of the captured region of the gene combination. For example, the second tumor mutation load in the captured region of the gene combination is determined by dividing the second number of mutations in the captured region of the gene combination whose variant allele frequency is greater than a predetermined value by the length of the captured region of the gene combination.

[0044] At box 210, the electronic device 110 determines a state of a tumor mutation load of the target object based on the first tumor mutation load and a plurality of second tumor mutation loads associated with a plurality of whole exome sequencing results.

[0045] Therefore, by obtaining multiple whole exome sequencing results of multiple objects associated with the target tumor type, and determining the second tumor mutation load summarized in the capture region of the gene combination for each whole exome sequencing result, the state of the tumor mutation load of the target object can be determined based on the multiple second tumor mutation loads associated with the multiple whole exome sequencing results, thereby achieving the determination of the state of the tumor mutation load for the gene combination and tumor type.

[0046] Figure 3 FIG. 3 is a flowchart of a method 300 for determining a state of a tumor mutation load of a target object according to an embodiment of the present disclosure. For example, the method 300 may be performed as follows: Figure 1 The method 300 is performed by the electronic device 110 shown. It should be understood that the method 300 may further include additional blocks not shown and / or may omit the blocks shown, and the scope of the present disclosure is not limited in this respect.

[0047] At block 302 , the electronic device 110 determines a predetermined quantile among a plurality of second tumor mutation loads as a threshold for a tumor mutation load associated with a target tumor type.

[0048] The predetermined quantile includes, for example, but is not limited to, the upper third quantile. For example, the plurality of second tumor mutation loads may be sorted from high to low to generate a sorting result, and the upper third quantile in the sorting result is determined as a threshold for the tumor mutation load.

[0049] At block 304 , the electronic device 110 determines whether the first tumor mutation load is greater than a threshold.

[0050] If the electronic device 110 determines at block 304 that the first tumor mutation load is greater than a threshold, then at block 306 it is determined that the status of the tumor mutation load of the target subject is high.

[0051] If the electronic device 110 determines at block 304 that the first tumor mutation load is less than or equal to the threshold, then at block 308 it is determined that the status of the tumor mutation load of the target subject is low.

[0052] Therefore, by using a predetermined quantile among multiple second tumor mutation loads of multiple objects associated with the target tumor type as a threshold for the tumor mutation load to evaluate the level of the tumor mutation load of the target object, the differences in the distribution of tumor mutation loads between different tumor types are fully considered, and the level of the tumor mutation load can be accurately determined based on the tumor type.

[0053] Taking a gene panel of 642 genes as an example, first extract the whole exome sequencing results of all patients with the same cancer type as the patient, then screen the mutations in the region captured by the gene panel, and simulate the gene panel to capture the sequencing results. Draw a distribution map of the cancer type and mark the relative position of the patient. The results show that the results of the gene panel are consistent with the whole exome sequencing results, such as Figure 4 As shown, the left side is the result of gene combination, and the right side is the result of whole exome sequencing. The two results are very similar, indicating that the disclosed solution is feasible.

[0054] Figure 5 Schematic block diagram of an example device 500 that can be used to implement embodiments of the present disclosure is shown. Figure 1 The electronic device 110 shown can be implemented by device 500. As shown, device 500 includes a central processing unit (CPU) 501, which can perform various appropriate actions and processes according to computer program instructions stored in a read-only memory (ROM) 502 or computer program instructions loaded from a storage unit 508 into a random access memory (RAM) 503. In the random access memory 503, various programs and data required for the operation of the device 500 can also be stored. The central processing unit 501, the read-only memory 502 and the random access memory 503 are connected to each other via a bus 504. An input / output (I / O) interface 505 is also connected to the bus 504.

[0055] A number of components in the device 500 are connected to the input / output interface 505, including: an input unit 506, such as a keyboard, a mouse, a microphone, etc.; an output unit 507, such as various types of displays, speakers, etc.; a storage unit 508, such as a disk, an optical disk, etc.; and a communication unit 509, such as a network card, a modem, a wireless communication transceiver, etc. The communication unit 509 allows the device 500 to exchange information / data with other devices through a computer network such as the Internet and / or various telecommunication networks.

[0056] The various processes and processing described above, such as methods 200 and 300, may be performed by the central processing unit 501. For example, in some embodiments, the methods 200 and 300 may be implemented as a computer software program, which is tangibly contained in a machine-readable medium, such as a storage unit 508. In some embodiments, part or all of the computer program may be loaded and / or installed on the device 500 via the read-only memory 502 and / or the communication unit 509. When the computer program is loaded into the random access memory 503 and executed by the central processing unit 501, one or more actions of the methods 200 and 300 described above may be performed.

[0057] The present disclosure relates to methods, apparatuses, systems, electronic devices, computer-readable storage media and / or computer program products. The computer program products may include computer-readable program instructions for executing various aspects of the present disclosure.

[0058] A computer-readable storage medium may be a tangible device that can hold and store instructions used by an instruction execution device. A computer-readable storage medium may be, for example, but not limited to, an electrical storage device, a magnetic storage device, an optical storage device, an electromagnetic storage device, a semiconductor storage device, or any suitable combination of the foregoing. More specific examples of computer-readable storage media (a non-exhaustive list) include: a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), a static random access memory (SRAM), a portable compact disk read-only memory (CD-ROM), a digital versatile disk (DVD), a memory stick, a floppy disk, a mechanical encoding device, such as a punch card or a raised structure in a groove on which instructions are stored, and any suitable combination of the foregoing. As used herein, a computer-readable storage medium is not to be interpreted as a transient signal per se, such as a radio wave or other freely propagating electromagnetic wave, an electromagnetic wave propagating through a waveguide or other transmission medium (e.g., a light pulse through a fiber optic cable), or an electrical signal transmitted through a wire.

[0059] The computer-readable program instructions described herein can be downloaded from a computer-readable storage medium to each computing / processing device, or downloaded to an external computer or external storage device via a network, such as the Internet, a local area network, a wide area network, and / or a wireless network. The network can include copper transmission cables, optical fiber transmissions, wireless transmissions, routers, firewalls, switches, gateway computers, and / or edge servers. The network adapter card or network interface in each computing / processing device receives the computer-readable program instructions from the network and forwards the computer-readable program instructions for storage in the computer-readable storage medium in each computing / processing device.

[0060] The computer program instructions for performing the operation of the present disclosure may be assembly instructions, instruction set architecture (ISA) instructions, machine instructions, machine-related instructions, microcode, firmware instructions, state setting data, or source code or object code written in any combination of one or more programming languages, including object-oriented programming languages, such as Smalltalk, C++, etc., and conventional procedural programming languages, such as "C" language or similar programming languages. Computer-readable program instructions may be executed completely on a user's computer, partially on a user's computer, as an independent software package, partially on a user's computer, partially on a remote computer, or completely on a remote computer or server. In the case of a remote computer, the remote computer may be connected to the user's computer via any type of network, including a local area network (LAN) or a wide area network (WAN), or may be connected to an external computer (e.g., using an Internet service provider to connect via the Internet). In some embodiments, an electronic circuit, such as a programmable logic circuit, a field programmable gate array (FPGA), or a programmable logic array (PLA), may be customized by utilizing the state information of the computer-readable program instructions, and the electronic circuit may execute the computer-readable program instructions, thereby realizing various aspects of the present disclosure.

[0061] Various aspects of the present disclosure are described herein with reference to the flowcharts and / or block diagrams of the methods, devices (systems) and computer program products according to the embodiments of the present disclosure. It should be understood that each box in the flowchart and / or block diagram and the combination of each box in the flowchart and / or block diagram can be implemented by computer-readable program instructions.

[0062] These computer-readable program instructions can be provided to a processing unit of a general-purpose computer, a special-purpose computer, or other programmable data processing device, thereby producing a machine, so that when these instructions are executed by the processing unit of the computer or other programmable data processing device, a device that implements the functions / actions specified in one or more boxes in the flowchart and / or block diagram is generated. These computer-readable program instructions can also be stored in a computer-readable storage medium, and these instructions cause the computer, programmable data processing device, and / or other equipment to work in a specific manner, so that the computer-readable medium storing the instructions includes a manufactured product, which includes instructions for implementing various aspects of the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0063] Computer-readable program instructions may also be loaded onto a computer, other programmable data processing apparatus, or other device so that a series of operating steps are performed on the computer, other programmable data processing apparatus, or other device to produce a computer-implemented process, thereby causing the instructions executed on the computer, other programmable data processing apparatus, or other device to implement the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0064] The flow chart and block diagram in the accompanying drawings show the possible architecture, function and operation of the system, method and computer program product according to multiple embodiments of the present disclosure. In this regard, each square box in the flow chart or block diagram can represent a part of a module, program segment or instruction, and a part of the module, program segment or instruction includes one or more executable instructions for realizing the specified logical function. In some alternative implementations, the function marked in the square box can also occur in a sequence different from that marked in the accompanying drawings. For example, two continuous square boxes can actually be executed substantially in parallel, and they can sometimes be executed in reverse order, depending on the functions involved. It should also be noted that each square box in the block diagram and / or flow chart, and the combination of the square boxes in the block diagram and / or flow chart can be implemented with a dedicated hardware-based system that performs the specified function or action, or can be implemented with a combination of special hardware and computer instructions.

[0065] The embodiments of the present disclosure have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or technical improvements to the technology in the market, or to enable other persons of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A method for determining the status of a tumor mutation load, comprising: Acquiring sequencing data for a gene combination and a length of a capture region of the gene combination, wherein the sequencing data is associated with a tumor sample of a target subject, and the tumor sample is associated with a target tumor type; Based on the sequencing data, determining a first number of mutations having a variant allele frequency greater than a predetermined value, and determining a first tumor mutation load based on the first number and the length; Acquire multiple whole exome sequencing result sets of multiple subject sets associated with multiple tumor types, wherein the multiple tumor types include the target tumor type, and acquire multiple whole exome sequencing results of multiple subjects associated with the target tumor type from the multiple whole exome sequencing result sets; For each whole exome sequencing result in the multiple whole exome sequencing results, based on the whole exome sequencing result, determine a second number of mutations in the captured region of the gene combination whose variant allele frequency is greater than the predetermined value, based on the second number and the length, determine a second tumor mutation load in the captured region of the gene combination; and based on the first tumor mutation load and multiple second tumor mutation loads associated with the multiple whole exome sequencing results, determining a predetermined quantile among the plurality of second tumor mutation loads as a threshold for the tumor mutation load associated with the target tumor type; If it is determined that the first tumor mutation load is greater than the threshold, determining that the state of the tumor mutation load of the target object is high; and If it is determined that the first tumor mutation load is less than or equal to the threshold, the state of the tumor mutation load of the target object is determined to be low.

2. The method according to claim 1, wherein the mutation comprises a synonymous mutation and a non-synonymous mutation. The method according to claim 1 , wherein the plurality of object sets and the target object belong to the same population. The method of claim 1 , wherein the plurality of sets of objects are associated with a plurality of populations, and the plurality of objects and the target object belong to the same population.

5. An electronic device comprising: at least one processor; as well as a memory communicatively connected to the at least one processor; wherein, The memory stores instructions that can be executed by the at least one processor, and the instructions are executed by the at least one processor to enable the at least one processor to perform the method according to any one of claims 1 to 4.

6. A computer-readable storage medium, characterized in that: A computer program is stored thereon, and when the program is executed by a processor, the method according to any one of claims 1 to 4 is implemented.

Citation Information

Patent Citations

  • Tumor abrupt change load detection method, tumor abrupt change load detection device, storage medium and processor

    CN109817279A

  • Tumor mutation load detection device and method based on capture sequencing technology

    CN112029861A

  • Method and application for selecting design interval for analyzing tumor mutation load

    CN113257349A